Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

NCT02535091 is registered in ClinicalTrials.gov with SK Life Science, Inc. as lead sponsor.

NCT NCT02535091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02535091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
Lead sponsor
SK Life Science, Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 3, 2016
Completion date
February 7, 2022
Enrollment
1,345 (actual)
Sites
121

Conditions

As the registry lists them; a condition with its own page is linked.

partial epilepsy